PYPD
PYPD
NASDAQ · Pharmaceuticals

Polypid Ltd

$4.44
-0.06 (-1.33%)
As of May 9, 2:10 AM ET ·
Financial Highlights (FY 2025)
Revenue
23.69M
Net Income
4.47M
Gross Margin
43.1%
Profit Margin
18.9%
Rev Growth
+11.0%
D/E Ratio
0.08
Revenue & Net Income
Margin Trends
FY 2025 FY 2024 FY 2023
Gross Margin 43.1% 43.1% 43.1%
Operating Margin 27.2% 26.8% 26.4%
Profit Margin 18.9% 19.1% 21.2%
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 23.69M 23.13M 22.16M
Gross Profit 10.20M 9.96M 9.54M
Operating Income 6.44M 6.21M 5.84M
Net Income 4.47M 4.40M 4.69M
Gross Margin 43.1% 43.1% 43.1%
Operating Margin 27.2% 26.8% 26.4%
Profit Margin 18.9% 19.1% 21.2%
Rev Growth +11.0% +7.8% +15.1%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 4.60M 5.17M 4.28M
Total Equity 56.27M 54.67M 47.29M
D/E Ratio 0.08 0.09 0.09
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA 8.95M 8.70M 7.31M
Free Cash Flow 3.30M 3.54M 2.93M